Granules India Limited
Indian Pharmaceutical Exporter ยท Analgesics & Antipyretics Specialist ยท $412.3M Total Trade ยท DGFT Verified
Granules India Limited is an Indian pharmaceutical exporter with a total trade value of $412.3M across 20 products in 9 therapeutic categories. Based on 8,357 verified export shipments from Indian Customs (DGFT) records, Granules India Limited is the #1 Indian exporter in 5 products including Metformin, Acetaminophen, Amino. Top exports include Metformin ($113.9M), Acetaminophen ($85.0M), Amino ($85.0M).
Granules India Limited โ Export Portfolio & Destination Treemap

Who is Granules India Limited? โ Company Overview & Market Position
Granules India Limited, established in 1984, is a vertically integrated pharmaceutical company headquartered in Hyderabad, Telangana, India. The company specializes in the manufacture and sale of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosage Forms (FDs). Granules India Limited is publicly listed on the National Stock Exchange of India (NSE) under the ticker symbol GRANULES and on the Bombay Stock Exchange (BSE) under the ticker symbol 532482. As of March 2025, the company employed approximately 6,166 individuals.
The company's Corporate Identification Number (CIN) is L24110TG1991PLC012471, and it is registered with the Registrar of Companies in Hyderabad. Granules India Limited's authorized share capital is โน505,000,000, with a paid-up capital of โน242,368,716. The company's official website is www.granulesindia.com.